Activity
Invited speakerDescription
Abstract submitted was selected for an invited short talk at a highly reputable international conference. Nimesh Mody gave the talk on Day 1 in the Session on Fatty Liver covering his work on Fenretinide and Hsd17b13.| Period | 2024 |
|---|---|
| Event title | Exploring the links between obesity and its adverse health outcomes |
| Event type | Conference |
| Location | Cambridge, United KingdomShow on map |
| Degree of Recognition | International |
Documents & Links
Related content
-
Research output
-
Hydroxysteroid 17-beta dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice
Research output: Contribution to journal › Article › peer-review
-
Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice
Research output: Contribution to journal › Article › peer-review